Parkinson's Disease

Spanning nearly 100 laboratories in 45 countries, a landmark study has, for the first time, shown an association between genetic brain shape and size and the prevalence of neurological conditions such as Parkinson's disease and ADHD.

Although brain-implanted electrodes do reduce the effects of neurological disorders, implanting and activating those electrodes is a tricky process. That's why scientists are now developing an alternative, in the form of injectable magnetic discs.

A drug used to induce labor in pregnant women has been shown to reactivate tiny waste-clearing pumps in the brains of old mice. The finding could hold promise for fighting Alzheimer's and Parkinson's diseases and overall cognitive decline.

Brain parasites are something that most people would naturally want to avoid, but maybe they can be used for good. A new study has found that a common brain parasite could be engineered to deliver drugs past the blood-brain barrier.

An innovative biodegradable paper that sticks to the brain’s surface like a Band-Aid and delivers electrical stimulation wirelessly could revolutionize the treatment of neurological diseases like Parkinson’s and Alzheimer’s, according to a new study.

The world’s most powerful MRI machine has scanned its first living human brains. The resulting images give an ultra high resolution glimpse into the brain, to help us better understand the nature of consciousness and treat neurodegenerative diseases.

If someone you know has gone through chemotherapy, you might be familiar with the side effect 'chemo brain.' Scientists have now demonstrated a simple way to protect brain cells from damage using flashing lights and sounds at a certain frequency.

Clinical trials using orally administered gold nanocrystals to treat multiple sclerosis and Parkinson’s disease have produced promising results. The nanocrystals restore crucial energy metabolites in the brain that are depleted in these conditions.

A study has found that a compound created by the body’s breakdown of a cancer drug has therapeutic properties that could be used in combination with the original drug to boost prostate cancer treatment or as a novel treatment for Parkinson's disease.

In yet another surprise attribute of the new class of obesity drugs, scientists have found that GLP-1 receptor agonists can also subdue brain inflammation, giving them a potential ‘superpower’ in the fight against Alzheimer’s and Parkinson’s diseases.

When it comes to the treatment of Parkinson's disease, electrical deep brain stimulation (DBS) is a commonly used technique. It does have some drawbacks, however, which is why scientists are now looking to tiny wirelessly activated magnets instead.

Researchers have created a ‘two-headed’ drug that prevents the production of the toxic protein linked to Parkinson’s disease before destroying the RNA machinery that makes it. The drug may be a way of slowing or even stopping the disease’s progression.